美国2010年最热销的200种药物的排名综观美国医改政策的动向

Overview on Medical Reform by US from List of TOP 200 Drugs in 2010

近年来,美国处方药市场中一个显著的新动向,即价格相对低廉的仿制药品的使用品种不断增加,患者用在药品上费用的支出不断减少。与此相反,使用价格昂贵的创新药物和新药的患者的数量大大减少(特别是治疗慢性病的药品)。这种趋势,即使用创新药物转向使用仿制药物十分强劲。由此看出,美国医改政策的一个侧面。

In recent years, an obvious tendency in the prescription drug market has been appearing in U.S.A, that is, the use of the generic drugs of relatively lower price increasingly replaces the use of brand drug of higher price. The patients spend much less money in purchasing drugs than before. Besides, the patients greatly decreased on using brand drugs and new drugs. The people may overview clearly the medical reform by from the list of TOP 200 drugs in 2010.